Anjali Tiwari

Anjali Tiwari

Active Director Director DIN 06626924
DIN 06626924 First appointment Aug 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Aug 2013
Shareholding value •••• Premium profile

About Anjali Tiwari

Data last updated:

Anjali Tiwari is a Director at Kulbhushan Pharmaceuticals (India) Private Limited (since 2013), Director at View Plus Clinic Private Limited (since 2015) and Director at Ashray Welfare Foundation Of India (since 2013). The companies operate in Pharma, Trading and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹15.5 Lakh; the largest is Kulbhushan Pharmaceuticals (India) Private Limited at ₹9 Lakh (FY 2014). Earlier, Anjali Tiwari was an Additional Director at Lahavana Infrastructures Private Limited (2020) and Additional Director at Kulbhushan Trading India Private Limited (from 2013).

DIN 06626924
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2013
Oldest Company Age 15 yrs
Largest company Kulbhushan Pharmaceuticals (India) Private Limited · ₹9 Lakh (FY 2014)
Combined revenue ₹15.5 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Aug 20132012₹9 Lakh (FY 2014)Active
View Plus Clinic Private Limited U74999DL2015PTC276823
Director18 Feb 20152015₹6.5 Lakh (FY 2024)Active
Ashray Welfare Foundation Of India U93000DL2011NPL223518
Director28 Aug 20132011Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director26 Feb 20202019₹39,583 (FY 2021)Active
Additional Director28 Aug 20132011₹5 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kulbhushan Pharmaceuticals (India) Private Limited
Kulbhushan Trading India Private Limited
View Plus Clinic Private Limited
Ashray Welfare Foundation Of India
Premium access

Shareholding and investment profile for Anjali Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Tiwari

Anjali Tiwari currently holds 3 directorships: Kulbhushan Pharmaceuticals (India) Private Limited (Director, since 28 Aug 2013, revenue ₹9 Lakh (FY 2014)); View Plus Clinic Private Limited (Director, since 18 Feb 2015, revenue ₹6.5 Lakh (FY 2024)); Ashray Welfare Foundation Of India (Director, since 28 Aug 2013).

Anjali Tiwari was first appointed on 28 Aug 2013 as Director at Kulbhushan Pharmaceuticals (India) Private Limited. The most recent appointment on record is 26 Feb 2020 at Lahavana Infrastructures Private Limited.

The 2 current companies of Anjali Tiwari that report revenue have a combined latest revenue of ₹15.5 Lakh: Kulbhushan Pharmaceuticals (India) Private Limited ₹9 Lakh (FY 2014); View Plus Clinic Private Limited ₹6.5 Lakh (FY 2024).

Anjali Tiwari held 2 earlier board appointments: Lahavana Infrastructures Private Limited (Additional Director, 26 Feb 2020 to 14 Aug 2020); Kulbhushan Trading India Private Limited (Additional Director, from 28 Aug 2013).

The current boards of Anjali Tiwari's companies include Abhay Kumar (Kulbhushan Pharmaceuticals (India) Private Limited), Anil Kumar Tiwari (Kulbhushan Pharmaceuticals (India) Private Limited), Ankita Tiwari (View Plus Clinic Private Limited), Harshit Rajawat (View Plus Clinic Private Limited), Kulbhushan Tiwari (View Plus Clinic Private Limited), Rita Upadhyaya (View Plus Clinic Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available